echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Clin Trans Gastroenterology: Alpha-fetoprotein (AFP) and CA19-9 are good prognostic indicators for predicting intrahepatic cholangiocarcinoma

    Clin Trans Gastroenterology: Alpha-fetoprotein (AFP) and CA19-9 are good prognostic indicators for predicting intrahepatic cholangiocarcinoma

    • Last Update: 2021-12-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer after hepatocellular carcinoma (HCC).


    Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer after hepatocellular carcinoma (HCC).


     

    Researchers collected 12 newly diagnosed ICC patients who underwent R0 resection between March 2009 and 2019 and followed up


     

    The results show that double negative AFP and CA19-9 lower proportion of patients at risk for lymph node transfer of advanced tumors, and larger tumor size, multiple tumors, lymph node metastasis, micro- vascular risk violations and violations of the surrounding nerves


    Blood vessel

     

    This study confirmed that the double negative of CA19-9 and AFP indicates that ICC patients have less aggressive tumors


    This study confirmed that the double negative of CA19-9 and AFP indicates that ICC patients have less aggressive tumors


    Zhang, Xiaoyun.


    Double-Negative α-Fetoprotein and Carbohydrate Antigen 19-9 Predict a Good Prognosis in Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.